O-38 Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013; revlimid) in transfusion dependent (TD) MDS with chromosome 5Q31.1 deletion: Results of the multicenter MDS-003 study
Titel:
O-38 Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013; revlimid) in transfusion dependent (TD) MDS with chromosome 5Q31.1 deletion: Results of the multicenter MDS-003 study